Dkc1 Related Disorder Cn294808
A rare genetic disorder affecting telomeres, leading to bone marrow failure, skin changes, and increased cancer risk. Treatment requires regular monitoring and addressing specific complications.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Easy bruising
(hematologic)Recurrent infections
(hematologic)Shortness of breath
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Bone marrow failure surveillance
Regular complete blood counts and bone marrow evaluation to monitor for progressive bone marrow failure, a major complication of DKC1-related dyskeratosis congenita. Early detection allows for timely intervention.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Cancer surveillance program
Regular screening for head and neck cancers, anogenital cancers, and other malignancies at increased risk in dyskeratosis congenita. Includes regular dermatological and otolaryngological examinations.
Additional treatment options
Mucocutaneous symptom management
Topical and systemic treatments for skin manifestations, nail dystrophy, and oral leukoplakia including retinoids, moisturizers, antibiotics for secondary infections, and surveillance of oral lesions.
medicationHematopoietic stem cell transplantation
Curative approach for bone marrow failure through HSCT when suitable donors are available. Requires careful evaluation given increased risk of complications in dyskeratosis congenita.
surgicalGenetic counseling and family screening
Comprehensive genetic counseling for patients and families including X-linked inheritance pattern explanation, carrier testing for female relatives, and discussion of reproductive options.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Dkc1 Related Disorder Cn294808?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Dkc1 Related Disorder Cn294808. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy